- Oct 13, 2020

ICR to study fadraciclib to treat paediatric neuroblastoma

The Institute of Cancer Research (ICR) in the UK is set to conduct clinical trials of a new drug candidate, fadraciclib, to potentially treat the aggressive childhood cancer neuroblastoma.

Bone cancer drug could save children’s lives

Splicing Deregulation Detected and Targeted in Type of Childhood Leukemia

New study uncovers key culprit behind pediatric brain cancer metastasis

Safe to Skip Primary Tumor Boosts in Pediatric Germinomas

Scientists reveal how different cancer cells team up to help incurable childhood brain tumour spread

Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

Childhood Cancer Survivors Have Higher Rate of Aging-Related Mutations Than the General Population

Children’s Cancer Institute begins trial for childhood brain cancer therapy

Drug Offers Long-Term Heart Protection for Childhood Cancer Survivors

World-first guidelines created to prevent heart complications in children during cancer treatment

Recent Posts

ICR to study fadraciclib to treat paediatric neuroblastoma

Archive

Search By Tags